The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Somatic HIF2A Gain-of-Function Mutations in Paraganglioma with Polycythemia
Open accessAbstract
Sum m a r yHypoxia-inducible factors are transcription factors controlling energy, iron metabolism, erythropoiesis, and development.When these proteins are dysregulated, they contribute to tumorigenesis and cancer progression.However, mutations in genes encoding α subunits of hypoxia-inducible factors (HIF-α) have not previously been identified in any cancer.Here we report two novel somatic gain-of-function mutations in the gene encoding hypoxia-inducible factor 2α (HIF2A) in two patients, one presenting with paraganglioma and the other with paraganglioma and somatostatinoma, both of whom had polycythemia.The two mutations were associated with increased HIF-2α activity and increased protein half-life.H ypoxia-inducible factors, originally described by Wang et al., 1 are transcription factors that respond to changes in tissue oxygen concentration.These highly conserved proteins are composed of α and β subunits.The HIF-β subunit is constitutively expressed, whereas the α subunits are inducible by hypoxia and are associated with aggressive, treatment-refractory tumors.2,3 Under normoxic conditions, HIF-1α, HIF-2α, and HIF-3α are hydroxylated on specific prolyl residues, allowing for recognition by the von Hippel-Lindau (VHL) tumorsuppressor protein, ubiquitination, and rapid degradation through the proteasome.4 Under hypoxic conditions, prolyl hydroxylation of HIF-α proteins is reduced, resulting in their stabilization and, in turn, transcription of genes involved in the hypoxia response, including angiogenesis, glycolysis, apoptosis, proliferation, and growth.5,6 Paragangliomas and pheochromocytomas are catecholamine-producing tumors derived from the chromaffin cells of extraadrenal paraganglia and the adrenal medulla.7 The pioneering work of Neumann et al. 8 showed that about one fourth of these tumors were hereditary, a fraction that was subsequently estimated to be closer to one third, on the basis of the identification of mutations in several additional genes, including SDHA, SDHAF2, TMEM127, and MAX. 9 The identification of these genetic drivers led to the demonstration of HIF-α stabilization and dysregulation in paragangliomas and pheochromocytomas harboring mutations in VHL and succinate dehydrogenase (SDH).10,11 Somatostatinomas are somatostatin-producing neuroendocrine tumors believed to originate from neural-crest cells.They are occasionally diagnosed in patients with the VHL syndrome, multiple endocrine neoplasia type 1 or 2, or neurofibromatosis type 1. 12
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Somatic gain-of-function mutations in HIF2A have been discovered in pheochromocytomas and paragangliomas (Zhuang et al., 2012;Comino-Mendez et al., 2013;Lorenzo et al., 2013;Taieb et al., 2013;Toledo et al., 2013;Yang et al., 2013), while high HIF-2α expression is associated with poor survival in patients with neuroblastoma (Holmquist-Mengelbier et al., 2006).”
From Therapeutic targeting of hypoxia and hypoxia-inducible factors in cancer (2016) · cites this paper as Zhuang et al., 2012
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Wang, G. L., Jiang, B. H., Rue, E. A., & Semenza, G. L. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.12.5510 · Cited by 6,212
Targeting Hypoxia-Inducible Factors for the Treatment of Anemia in Chronic Kidney Disease Patients
Locatelli, F., Fishbane, S. N., Block, G. A., & Macdougall, I. C. (2017) · American Journal of Nephrology · doi:10.1159/000455166 · Cited by 4,836
Oxygen sensing by metazoans: the central role of the HIF hydroxylase pathway.
Kaelin, W. G., & Ratcliffe, P. J. (2008) · Molecular Cell · doi:10.1016/j.molcel.2008.04.009 · Cited by 3,251
A conserved family of prolyl-4-hydroxylases that modify HIF
Bruick, R. K., & McKnight, S. L. (2001) · Science · doi:10.1126/science.1066373 · Cited by 2,549
HIF1α and HIF2α: sibling rivalry in hypoxic tumour growth and progression
Keith, B., Johnson, R. S., & Simon, M. C. (2012) · Nature Reviews Cancer · doi:10.1038/nrc3183 · Cited by 1,693
Lenders, J. W. M., Eisenhofer, G., Mannelli, M., & Pacák, K. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67139-5 · Cited by 1,541
Hypoxia-inducible factors: mediators of cancer progression and targets for cancer therapy
Semenza, G. L. (2012) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2012.01.005 · Cited by 1,514
Differential Roles of Hypoxia-Inducible Factor 1α (HIF-1α) and HIF-2α in Hypoxic Gene Regulation
Hu, C.-J., Wang, L.-Y., Chodosh, L. A., Keith, B., & Simon, M. C. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.24.9361-9374.2003 · Cited by 1,386
The impact of O2 availability on human cancer
Bertout, J. A., Patel, S. A., & Simon, M. C. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2540 · Cited by 1,365
Germ-Line Mutations in Nonsyndromic Pheochromocytoma
Neumann, H. P. H., Bausch, B., McWhinney, S. R., Bender, B., Gimm, O., Franke, G., Schipper, J., Klisch, J., Altehoefer, C., Zerres, K., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa020152 · Cited by 1,350
Flagged first, then by citations
Research works printed but not linked: 3
- Vinik AI, 1987, Semin Oncol, 14, 263
- Morris MR, 2009, Anticancer Res, 29, 4337
- Prchal JT, 2008, N Engl J Med, 358, 1966
Cited by
Sorted by citations
Items 101–200 of 393
SDHD Immunohistochemistry: A New Tool to ValidateSDHxMutations in Pheochromocytoma/Paraganglioma
Menara, M., Oudijk, L., Badoual, C., Bertherat, J. Y., Lussey‐Lepoutre, C., Amar, L., Iturrioz, X., Sibony, M., Zinzindohoué, F., de Krijger, R. R., et al. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-1870 · Cited by 55
Genetics of pheochromocytoma and paraganglioma syndromes
Vícha, A., Musil, Z., & Pacák, K. (2013) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0b013e32835fcc45 · Cited by 54
Fielding, J. W., Hodson, E. J., Cheng, X., Ferguson, D. J. P., Eckardt, L., Adam, J., Lip, P., Maton‐Howarth, M., Ratnayaka, I., Pugh, C. W., et al. (2018) · The Journal of Physiology · doi:10.1113/jp275996 · Cited by 55
Hypoxia, pseudohypoxia and cellular differentiation
Mohlin, S., Wigerup, C., Jögi, A., & Påhlman, S. (2017) · Experimental Cell Research · doi:10.1016/j.yexcr.2017.03.007 · Cited by 54
Koopman, K., Gaal, J., & de Krijger, R. R. (2019) · Cancers · doi:10.3390/cancers11081070 · Cited by 55
Oudijk, L., de Krijger, R. R., Rapa, I., Beuschlein, F., de Cubas, A. A., Tos, A. P. D., Dinjens, W. N. M., Korpershoek, E., Mančíková, V., Mannelli, M., et al. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-3879 · Cited by 56
Lowery, A., Walsh, S. M., McDermott, E. W. M., & Prichard, R. S. (2013) · The Oncologist · doi:10.1634/theoncologist.2012-0410 · Cited by 53
Genetic mechanisms of human hypertension and their implications for blood pressure physiology
Seidel, E., & Scholl, U. I. (2017) · Physiological Genomics · doi:10.1152/physiolgenomics.00032.2017 · Cited by 52
Liu, S., Wang, J., Peng, S., Li, T., Ning, X., Hong, B., Liu, J., Wu, P., Zhou, B., Zhou, J., et al. (2018) · Genetics in Medicine · doi:10.1038/gim.2017.261 · Cited by 50
Mohlin, S., Hamidian, A., & Påhlman, S. (2013) · Neoplasia · doi:10.1593/neo.121706 · Cited by 49
Familial pheochromocytomas and paragangliomas
King, K. S., & Pacák, K. (2013) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2013.07.032 · Cited by 51
HIF Signaling Pathway in Pheochromocytoma and Other Neuroendocrine Tumors
Jochmanová, I., Zelinka, T., Widimsky, J., Jr., & Pacák, K. (2014) · Physiological Research · doi:10.33549/physiolres.932789 · Cited by 49
Investigation and Management of Erythrocytosis
McMullin, M. F. (2016) · Current Hematologic Malignancy Reports · doi:10.1007/s11899-016-0334-1 · Cited by 49
The Adrenal Medulla and Extra-adrenal Paraganglia: Then and Now
Tischler, A. S., Pacák, K., & Eisenhofer, G. (2013) · Endocrine Pathology · doi:10.1007/s12022-013-9286-3 · Cited by 49
Roles of HIF and 2-Oxoglutarate-Dependent Dioxygenases in Controlling Gene Expression in Hypoxia
Frost, J., Frost, M. G., Batie, M., Jiang, H., & Rocha, S. (2021) · Cancers · doi:10.3390/cancers13020350 · Cited by 47
Functional Imaging Signature of Patients Presenting with Polycythemia/Paraganglioma Syndromes
Janssen, I., Chen, C. C., Zhuang, Z., Millo, C., Wolf, K. I., Ling, A. L., Lin, F. I., Adams, K. T., Herscovitch, P., Feelders, R. A., et al. (2017) · Journal of Nuclear Medicine · doi:10.2967/jnumed.116.187690 · Cited by 47
Self-citationPheochromocytomas and Paragangliomas: From Genetic Diversity to Targeted Therapies
Pang, Y. K., Liu, Y., Pacák, K., & Yang, C. (2019) · Cancers · doi:10.3390/cancers11040436 · Cited by 48
Self-citationPheochromocytoma and paraganglioma
Burnichon, N., Buffet, A., & Gimenez‐Roqueplo, A. (2015) · Current Opinion in Oncology · doi:10.1097/cco.0000000000000249 · Cited by 46
Genotype–phenotype correlation of hereditary erythrocytosis mutations, a single center experience
Oliveira, J. L., Coon, L. M., Frederick, L. A., Hein, M. S., Swanson, K. C., Savedra, M. E., Porter, T. R., Patnaik, M. M., Tefferi, A., Pardanani, A. D., et al. (2018) · American Journal of Hematology · doi:10.1002/ajh.25150 · Cited by 47
Papathomas, T. G., de Krijger, R. R., & Tischler, A. S. (2013) · Seminars in Diagnostic Pathology · doi:10.1053/j.semdp.2013.06.006 · Cited by 44
The Genetic Basis of Pheochromocytoma and Paraganglioma: Implications for Management
Shuch, B. M., Ricketts, C. J., Metwalli, A. R., Pacák, K., & Linehan, W. M. (2014) · Urology · doi:10.1016/j.urology.2014.01.007 · Cited by 44
HIF-2α-pVHL complex reveals broad genotype-phenotype correlations in HIF-2α-driven disease
Tarade, D., Robinson, C. M., Lee, J. E., & Ohh, M. (2018) · Nature Communications · doi:10.1038/s41467-018-05554-1 · Cited by 44
Molecular markers of paragangliomas/pheochromocytomas
Zhikrivetskaya, S. O., Snezhkina, A. V., Zaretsky, A. R., Alekseev, B. Y., Pokrovsky, A. V., Golovyuk, A. L., Melnikova, N. V., Stepanov, O. A., Kalinin, D. V., Moskalev, A., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.15201 · Cited by 45
Lanikova, L., Lorenzo, F., Yang, C., Vankayalapati, H., Drachtman, R. A., Divoký, V., & Prchal, J. T. (2013) · Blood · doi:10.1182/blood-2012-11-469296 · Cited by 45
Self-citationUpdates on Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitors in the Treatment of Renal Anemia
Li, J., Haase, V. H., & Hao, C. (2022) · Kidney Diseases · doi:10.1159/000527835 · Cited by 42
Crona, J., Verdugo, A. D., Granberg, D. O., Welin, S., Stalberg, P. L. H., Hellman, P., & Björklund, P. (2013) · Endocrine Connections · doi:10.1530/ec-13-0009 · Cited by 42
The VHL/HIF Axis in the Development and Treatment of Pheochromocytoma/Paraganglioma
Song, P., Zhang, J., Tan, X., Huang, Y., Xu, J., Silk, N., Zhang, D., Liu, Q., & Jiang, J. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.586857 · Cited by 42
Richter, S., Qin, N., Pacak, K., & Eisenhofer, G. (2013) · Advances in Pharmacology · doi:10.1016/b978-0-12-411512-5.00014-2 · Cited by 42
Two functional loci in the promoter of EPAS1 gene involved in high-altitude adaptation of Tibetans
Xu, X.-H., Huang, X.-W., Li, Q., Li, Y.-N., Wang, Y., Liu, C., Ma, Y., Liu, Q.-M., Sun, K., Qian, F., et al. (2014) · Scientific Reports · doi:10.1038/srep07465 · Cited by 41
Molecular Pathology of Well-Differentiated Gastro-entero-pancreatic Neuroendocrine Tumors
Asa, S. L., Rosa, S. L., Baştürk, O., Adsay, V. N., Minnetti, M., & Grossman, A. B. (2021) · Endocrine Pathology · doi:10.1007/s12022-021-09662-5 · Cited by 41
Genetics of pheochromocytoma and paraganglioma
Wachtel, H., & Fishbein, L. M. (2021) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0000000000000634 · Cited by 41
Crona, J., Nordling, M., Maharjan, R., Granberg, D. O., Stalberg, P. L. H., Hellman, P., & Björklund, P. (2014) · PLoS ONE · doi:10.1371/journal.pone.0086756 · Cited by 39
Toledo, R. A. (2017) · Endocrine Related Cancer · doi:10.1530/erc-16-0479 · Cited by 42
New Insights into the Nuclear Imaging Phenotypes of Cluster 1 Pheochromocytoma and Paraganglioma
Taïeb, D., & Pacák, K. (2017) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2017.08.001 · Cited by 40
Gieldon, L., William, D., Hackmann, K., Jahn, W., Jahn, A., Wagner, J., Rump, A., Bechmann, N., Nölting, S., Knösel, T., et al. (2019) · Cancers · doi:10.3390/cancers11060809 · Cited by 39
Couvé, S., Ladroue, C., Laine, É., Mahtouk, K., Guégan, J., Gad, S., Jeune, H. L., Gentil, M. L., Nuel, G., Kim, W. Y., et al. (2014) · Cancer Research · doi:10.1158/0008-5472.can-14-1161 · Cited by 41
Shankavaram, U. T., Fliedner, S. M. J., ELKAHLOUN, A. G., Barb, J. J., Munson, P. J., Huynh, T., Matro, J. C., Turková, H., Linehan, W. M., Timmers, H. J. L. M., et al. (2013) · Neoplasia · doi:10.1593/neo.122132 · Cited by 38
Pheochromocytoma and paraganglioma: germline genetics and hereditary syndromes
Turin, C. G., Crenshaw, M. M., & Fishbein, L. M. (2022) · Endocrine Oncology · doi:10.1530/eo-22-0044 · Cited by 37
Pang, Y., Yang, C., Schovanek, J., Wang, H., Bullova, P., Caisova, V., Gupta, G., Wolf, K. I., Semenza, G. L., Zhuang, Z., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.16224 · Cited by 37
Self-citationLi, S., Li, W., Yuan, J., Bullova, P., Wu, J., Zhang, X., Liu, Y., Plescher, M., Rodríguez, J., Bedoya-Reina, O. C., et al. (2022) · Nature Metabolism · doi:10.1038/s42255-022-00593-x · Cited by 36
Hamidian, A., von Stedingk, K., Thorén, M. M., Mohlin, S., & Påhlman, S. (2015) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2015.04.083 · Cited by 37
Current views on cell metabolism in SDHx-related pheochromocytoma and paraganglioma
Vícha, A., Taïeb, D., & Pacák, K. (2014) · Endocrine Related Cancer · doi:10.1530/erc-13-0398 · Cited by 35
Breakthrough science: hypoxia-inducible factors, oxygen sensing, and disorders of hematopoiesis
Semenza, G. L. (2021) · Blood · doi:10.1182/blood.2021011043 · Cited by 38
Boons, G., Vandamme, T., Peeters, M., Beyens, M., Driessen, A. L. C., Janssens, K., Zwaenepoel, K., Roeyen, G., Camp, G. V., & de Beeck, K. O. (2018) · Frontiers in Oncology · doi:10.3389/fonc.2018.00467 · Cited by 34
HIF-Prolyl Hydroxylase Domain Proteins (PHDs) in Cancer—Potential Targets for Anti-Tumor Therapy?
Gaete, D., Rodriguez, D., Watts, D., Sormendi, S., Chavakis, T., & Wielockx, B. (2021) · Cancers · doi:10.3390/cancers13050988 · Cited by 35
Human embryonic genetic mosaicism and its effects on development and disease
Waldvogel, S. M., Posey, J. E., & Goodell, M. A. (2024) · Nature Reviews Genetics · doi:10.1038/s41576-024-00715-z · Cited by 36
Flynn, A., Dwight, T., Harris, J., Benn, D. E., Zhou, L., Hogg, A., Catchpoole, D. R., James, P. A., Duncan, E. L., Trainer, A. H., et al. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-3889 · Cited by 34
Adrenocortical carcinoma and succinate dehydrogenase gene mutations: an observational case series
Else, T., Lerário, A. M., Everett, J. N., Haymon, L., Wham, D., Mullane, M. P., Wilson, T. L. S., Rainville, I. R., Rana, H. Q., Worth, A. J., et al. (2017) · European Journal of Endocrinology · doi:10.1530/eje-17-0358 · Cited by 33
Macklin, P. S., Yamamoto, A., Browning, L., Hofer, M., Adam, J., & Pugh, C. W. (2020) · The Journal of Pathology · doi:10.1002/path.5402 · Cited by 33
Management of familial cancer: sequencing, surveillance and society
Samuel, N., Villani, A., Fernandez, C. V., & Malkin, D. M. (2014) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2014.169 · Cited by 33
Pheochromocytomas and Paragangliomas: Bypassing Cellular Respiration
Cascón, A., Remacha, L., Calsina, B., & Robledo, M. (2019) · Cancers · doi:10.3390/cancers11050683 · Cited by 33
Guha, A., Musil, Z., Vícha, A., Zelinka, T., Pacák, K., Astl, J., & Chovanec, M. (2019) · Neoplasma · doi:10.4149/neo_2018_181208n933 · Cited by 32
Pacák, K., Chew, E. Y., Pappo, A. S., Yang, C., Lorenzo, F., Wilson, M. W., Aronow, M. E., Young, J. A., POPOVIC, V. M., & Zhuang, Z. (2014) · Ophthalmology · doi:10.1016/j.ophtha.2014.06.019 · Cited by 32
Self-citationCARM1 drives triple-negative breast cancer progression by coordinating with HIF1A
Feng, D., Gao, J., Liu, R., Liu, W., Gao, T., Yang, Y., Zhang, D., Yang, T., Yin, X., Yu, H., et al. (2024) · Protein & Cell · doi:10.1093/procel/pwae010 · Cited by 31
When should genetic testing be performed in patients with neuroendocrine tumours?
O’Shea, T., & Druce, M. R. (2017) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-017-9430-3 · Cited by 31
Hypoxia Signaling in Vascular Homeostasis
Marsboom, G., & Rehman, J. (2018) · Physiology · doi:10.1152/physiol.00018.2018 · Cited by 33
Pseudohypoxic pheochromocytomas and paragangliomas dominate in children
Redlich, A., Pamporaki, C., Lessel, L., Frühwald, M. C., Vorwerk, P., & Kuhlen, M. (2021) · Pediatric Blood & Cancer · doi:10.1002/pbc.28981 · Cited by 30
Celada, L., Cubiella, T., San‐Juan‐Guardado, J., Gutiérrez, G., Beiguela, B., Rodríguez, R. Q., Poch, M., Astudillo, A., Grijalba, A., Sobrino, P. S., et al. (2022) · The Journal of Pathology · doi:10.1002/path.6026 · Cited by 30
Polycythemia and Paraganglioma With a Novel Somatic HIF2A Mutation in a Male
Toyoda, H., Hirayama, J., Sugimoto, Y., Uchida, K., Ohishi, K., Hirayama, M., & Komada, Y. (2014) · PEDIATRICS · doi:10.1542/peds.2013-2419 · Cited by 29
The Endoplasmic Reticulum Cargo Receptor SURF4 Facilitates Efficient Erythropoietin Secretion
Lin, Z., King, R., Tang, V. T., Myers, G., Balbin-Cuesta, G., Friedman, A. D., McGee, B. M., Desch, K. C., Ozel, A. B., Siemieniak, D. R., et al. (2020) · Molecular and Cellular Biology · doi:10.1128/mcb.00180-20 · Cited by 30
Pheochromocytoma: Gasping for Air
Jochmanová, I., Zhuang, Z., & Pacák, K. (2015) · Hormones and Cancer · doi:10.1007/s12672-015-0231-4 · Cited by 30
Self-citationYang, C., Hong, C. S., Prchal, J. T., Balint, M. T., Pacák, K., & Zhuang, Z. (2015) · Human Genome Variation · doi:10.1038/hgv.2015.53 · Cited by 29
Self-citationPathophysiology and Diagnosis of Disorders of the Adrenal Medulla: Focus on Pheochromocytoma
Lenders, J. W. M., & Eisenhofer, G. (2014) · Comprehensive physiology · doi:10.1002/cphy.c130034 · Cited by 30
Cao, M., You, A., Cui, W., Zhang, S., Guo, Z., Chen, L., Zhu, X., Zhang, W., Zhu, X., Guo, H., et al. (2020) · The FASEB Journal · doi:10.1096/fj.202000082r · Cited by 28
Perrotta, S., Stiehl, D. P., Punzo, F., Scianguetta, S., Borriello, A., Bencivenga, D., Casale, M., Nobili, B., Fasoli, S., Balduzzi, A., et al. (2013) · Haematologica · doi:10.3324/haematol.2013.088369 · Cited by 29
HIF2A gain-of-function mutations detected in duodenal gangliocytic paraganglioma
Zhuang, Z., Yang, C., Ryška, A., Ji, Y., Hou, Y., Graybill, S. D., Bullova, P., Lubensky, I. A., Klöppel, G., & Pacák, K. (2016) · Endocrine Related Cancer · doi:10.1530/erc-16-0148 · Cited by 28
Self-citationKuo, M. J. M., Nazari, M. A., Jha, A., & Pacák, K. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.936178 · Cited by 30
Re-envisioning genetic predisposition to childhood and adolescent cancers
Kratz, C. P. (2024) · Nature reviews. Cancer · doi:10.1038/s41568-024-00775-7 · Cited by 29
Maria, A. G., Suzuki, M., Berthon, A. S., Kamilaris, C. D. C., Demidowich, A. P., Lack, J., Zilbermint, M. F., Hannah‐Shmouni, F., Faucz, F. R., & Stratakis, C. A. (2019) · American Journal of Hypertension · doi:10.1093/ajh/hpz172 · Cited by 26
Self-citationYamazaki, Y., Gao, X., Pecori, A., Nakamura, Y., Tezuka, Y., Omata, K., Ono, Y., Morimoto, R., Satoh, F., & Sasano, H. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.587769 · Cited by 30
A clinical and genetic analysis of multiple primary cancer referrals to genetics services
Whitworth, J., Hoffman, J., Chapman, C. J., Ong, K. R., Lalloo, F. I., Evans, D. G., & Maher, E. R. (2014) · European Journal of Human Genetics · doi:10.1038/ejhg.2014.157 · Cited by 26
Ke, S., Chen, S., Dong, Z., Hong, C. S., Zhang, Q., Tang, L., Yang, P., Zhai, J., Yan, H., Shen, F., et al. (2016) · Hepatology · doi:10.1002/hep.28889 · Cited by 28
Self-citationNotch signaling promotes a HIF2α-driven hypoxic response in multiple tumor cell types
Mutvei, A. P., Landor, S. K.-J., Fox, R., Braune, E.-B., Tsoi, Y. L., Phoon, Y. P., Sahlgren, C., Hartman, J., Bergh, J. C. S., Jin, S., et al. (2018) · Oncogene · doi:10.1038/s41388-018-0400-3 · Cited by 26
A Transgenic Mouse Model of Pacak–Zhuang Syndrome with An Epas1 Gain-of-Function Mutation
Wang, H., Cui, J., Yang, C., Rosenblum, J. S., Zhang, Q., Song, Q., Pang, Y. K., Fang, F. Y., Sun, M., Dmitriev, P., et al. (2019) · Cancers · doi:10.3390/cancers11050667 · Cited by 26
Self-citationDevelopmental vascular malformations in EPAS1 gain-of-function syndrome
Rosenblum, J. S., Wang, H., Dmitriev, P., Cappadona, A. J., Mastorakos, P., Xu, C., Jha, A., Edwards, N. A., Donahue, D., Munasinghe, J., et al. (2021) · JCI Insight · doi:10.1172/jci.insight.144368 · Cited by 26
Self-citationCancer Stem Cells in Pheochromocytoma and Paraganglioma
Scriba, L. D., Bornstein, S. R., Santambrogio, A., Mueller, G., Huebner, A., Hauer, J., Schedl, A., Wielockx, B., Eisenhofer, G., Andoniadou, C. L., et al. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.00079 · Cited by 25
Genetic testing in the clinical care of patients with pheochromocytoma and paraganglioma
Rana, H. Q., Rainville, I. R., & Vaidya, A. (2014) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0000000000000059 · Cited by 26
p27 variant and corticotropinoma susceptibility: a genetic and in vitro study
Sekiya, T., Bronstein, M. D., Benfini, K., Longuini, V. C., Jallad, R. S., Machado, M. C., Gonçalves, T. D., Osaki, L. H., Higashi, L., Viana-Jr, J., et al. (2014) · Endocrine Related Cancer · doi:10.1530/erc-13-0486 · Cited by 25
Regulation and dysregulation of astrocyte activation and implications in tumor formation
Yang, C.-Z., Rahimpour, S., Yu, A., Lonser, R., & Zhuang, Z. (2013) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-013-1274-8 · Cited by 32
Self-citationEpigenetics of pheochromocytoma and paraganglioma
Björklund, P., & Backman, S. (2017) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2017.06.016 · Cited by 25
New insights on the pathogenesis of paraganglioma and pheochromocytoma
Kantorovich, V., & Pacák, K. (2018) · F1000Research · doi:10.12688/f1000research.14568.1 · Cited by 24
NNT‐induced tumor cell “slimming” reverses the pro‐carcinogenesis effect of HIF2a in tumors
Xiong, Z., Xiong, W., Xiao, W., Yuan, C., Shi, J., Huang, Y., Wang, C., Meng, X., Chen, Z., Yang, H., et al. (2021) · Clinical and Translational Medicine · doi:10.1002/ctm2.264 · Cited by 24
Emerging role of dopamine in neovascularization of pheochromocytoma and paraganglioma
Osinga, T. E., Links, T. P., Dullaart, R. P. F., Pacák, K., van der Horst‐Schrivers, A. N. A., Kerstens, M. N., & Kema, I. P. (2017) · The FASEB Journal · doi:10.1096/fj.201601131r · Cited by 28
Backman, S., Maharjan, R., Falk-Delgado, A., Crona, J., Cupisti, K., Stalberg, P. L. H., Hellman, P., & Björklund, P. (2017) · Scientific Reports · doi:10.1038/srep44943 · Cited by 23
de Bresser, C. J. M., & de Krijger, R. R. (2024) · Endocrine Pathology · doi:10.1007/s12022-024-09830-3 · Cited by 22
Fliedner, S. M. J., Brabant, G. E., & Lehnert, H. (2018) · Cell and Tissue Research · doi:10.1007/s00441-017-2760-3 · Cited by 22
Genetic Background of Congenital Erythrocytosis
McMullin, M. F. (2021) · Genes · doi:10.3390/genes12081151 · Cited by 24
HIF-2alpha: Achilles' heel of pseudohypoxic subtype paraganglioma and other related conditions
Tella, S. H., Taïeb, D., & Pacák, K. (2017) · European Journal of Cancer · doi:10.1016/j.ejca.2017.08.023 · Cited by 24
A novel HIF2A mutation causes dyslipidemia and promotes hepatic lipid accumulation
Gao, F., Yao, Q., Zhu, J., Chen, W., Feng, X., Feng, B., Wu, J., Pacák, K., Rosenblum, J. S., Yu, J., et al. (2023) · Pharmacological Research · doi:10.1016/j.phrs.2023.106851 · Cited by 22
Self-citationHussain, I., Husain, Q. M., Baredes, S., Eloy, J. A., Jyung, R. W., & Liu, J. K. (2013) · Journal of neurosurgery · doi:10.3171/2013.10.jns13659 · Cited by 21
Hypoxia Pathway Mutations in Pheochromocytomas and Paragangliomas
Amorim-Pires, D., Peixoto, J., & Lima, J. P. (2016) · Cytogenetic and Genome Research · doi:10.1159/000457479 · Cited by 22
Pang, Y. K., Gupta, G., Jha, A., Yue, X., Wang, H., Huynh, T., Li, A., Li, L., Baker, E. H., Chew, E. Y., et al. (2019) · Cancer · doi:10.1002/cncr.31839 · Cited by 21
Self-citationTarade, D., Lee, J. E., & Ohh, M. (2019) · Nature Communications · doi:10.1038/s41467-019-11149-1 · Cited by 21
Bechmann, N., & Eisenhofer, G. (2021) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/a-1526-5263 · Cited by 21
Head and neck paragangliomas: what does the pathologist need to know?
Hayashi, T., & Mete, Ö. (2014) · Diagnostic histopathology · doi:10.1016/j.mpdhp.2014.06.002 · Cited by 21
Ogasawara, T., Fujii, Y. R., Kakiuchi, N., Shiozawa, Y., Sakamoto, R., Ogawa, Y., Ootani, K., Ito, E., Tanaka, T., Watanabe, K., et al. (2022) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgac362 · Cited by 21
Complex role of HIF in cancer: the known, the unknown, and the unexpected
Huang, E. L., Tiburcio, P. D. B., & Choi, H. (2014) · Hypoxia · doi:10.2147/hp.s50651 · Cited by 20
Merlo, A., Fernández, S. B. D. Q., Sáenz‐de‐Santa‐María, I., Pitiot, A. S., Balbı́n, M., Astudillo, A., Scola, B., Arístegui, M., Quer, M., Suarez, C. M., et al. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-1636 · Cited by 20
Pang, Y. K., Gupta, G., Yang, C., Wang, H., Huynh, T., Abdullaev, Z., Pack, S., Percy, M. J., Lappin, T. R. J., Zhuang, Z., et al. (2018) · BMC Cancer · doi:10.1186/s12885-018-4127-x · Cited by 20
Self-citationSomatic gain-of-function HIF2A mutations in sporadic central nervous system hemangioblastomas
Taïeb, D., Barlier, A., Yang, C., Pertuit, M., Tchoghandjian, A., Rochette, C., Zattara-Canoni, H., Figarella‐Branger, D., Zhuang, Z., Pacák, K., et al. (2015) · Journal of Neuro-Oncology · doi:10.1007/s11060-015-1983-y · Cited by 21
Self-citation
Metadata
- Authors
- Zhuang, Z., Yang, C., Lorenzo, F., Merino, M., Fojo, T., Kebebew, E., Popovic, V., Stratakis, C. A., Prchal, J. T., & Pacak, K.
- Affiliations
- National Institutes of Health (US)
- National Institute of Neurological Disorders and Stroke (US)
- Veterans Health Administration (US)
- National Cancer Institute (MY)
- National Cancer Institute (UA)
- University of Belgrade (RS)
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (US)
- University of Utah (US)
- ORCID
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2012-09-06
- Volume
- 367
- Issue
- 10
- Pages
- 922-930
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- PMC
- PMC3432945
- OpenAlex
- W2142033642
- Cited by
- 397
- References
- 26
- Citations by year
- 2026: 22 · 2025: 12 · 2024: 22 · 2023: 18 · 2022: 20 · 2021: 29 · 2020: 24 · 2019: 24 · 2018: 32 · 2017: 43 · 2016: 27 · 2015: 31 · 2014: 47 · 2013: 42 · 2012: 2
- FWCI
- 39.84
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institutes of Health
- National Cancer Institute (P01CA108671)
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (ZIAHD008735)
- Topics
- Health Sciences › Medicine › Surgery › Adrenal and Paraganglionic Tumors
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Health Sciences › Medicine › Oncology › Ear and Head Tumors
- Keywords
- HIF-2α, paraganglioma, polycythemia, somatostatinoma, gain-of-function mutations, protein half-life, prolyl hydroxylation, VHL, succinate dehydrogenase, pheochromocytoma
- MeSH terms
- Abdominal Neoplasms, Endothelial PAS Domain-Containing Protein 1, Adolescent, Adrenal Gland Neoplasms, Adult, DNA Mutational Analysis, Female, Humans, Hydroxylation, Mutation, Pancreatic Neoplasms, Paraganglioma, Polycythemia, Somatostatinoma, Transcription, Genetic, Up-Regulation, Basic Helix-Loop-Helix Transcription Factors, Basic Helix-Loop-Helix Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
